Dr.sci.med Strahinja Odalović

Radno iskustvo:

• 2008-2010 zaposlen na Odeljenju radiologije Univerzitetske dečje klinike u Beogradu, kao klinički lekar na određeno vreme;
• od 10. februara 2010.  stalno zaposlen u Centru za nuklearnu medicinu, Univerzitetskog kliničkog centra Srbije
• od 2014 zaposlen u svojstvu lekara specijaliste nuklearne medicine u Centru za nuklearnu medicinu, Univerzitetskog kliničkog centra Srbije
• 2015-16 šef odseka za nuklearnu endokrinologiju u Centru za nuklearnu medicinu Univerzitetskog kliničkog centra Srbije
• od 2015 angažovan na Medicinskom fakultetu Univerziteta u Beogradu u zvanju kliničkog asistenta na Katedri nuklearne medicine
• od 2019 zaposlen u svojstvu lekara specijaliste nuklearne medicine i specijaliste radiologije, u Centru za nuklearnu medicinu, Univerzitetskog kliničkog centra Srbije

Usavršavanja:

• Studijski boravak - Klinička aplikacija PET/CT, „Hammersmith Hospital“, Imperial College Healthcare NHS, London, UK
• Primena PET/CT – naučna poseta, IAEA, Scanomed Debrecen, Mađarska
• Regionalni kurs primene hibridnog imidžinga: SPECT/CT i PET/CT, IAEA, Piza, Italija
• PET/CT u onkologiji – bazični kurs, Evropsko udruženje za nuklearnu medicinu (EANM), Beč, Austrija
• seminar Evropske škole za nuklearnu medicinu u Pragu, Češka republika
• seminar Evropske škole za nuklearnu medicinu u Beogradu
• Kurs primene nuklearno-medicinskih metoda u pedijatriji, EANM, Beč, Austrija
• seminar Evropske škole za nuklearnu medicinu u Budimpešti, Mađarska

Spisak publikacija:

1. Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J, Vucinic-Mihailovic V, Artiko V, Saranovic D, Djuric-Stefanovic A, Masulovic D, Odalovic S, Ilic-Dudvarski A, Popevic S, Pavlovic S, Obradovic V. The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nucl Med 2012; 53:1543-9.
2. Ristić AJ, Marjanović I, Brajković L, Wolgamuth BR, Odalović S, Lavrnić S, Vojvodić N, Janković S, Baščarević V, Sokić D. Bálint-like syndrome as an unusual representation of non-convulsive status epilepticus. Epileptic Disord 2012;14:80-4.
3. Artiko V, Sobic-Saranovic D, Pavlovic S, Petrovic M, Zuvela M, Antic A, Matic S, Odalovic S, Petrovic N, Milovanovic A, Obradovic V. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC. J BUON 2012;17:537-42.
4. Artiko V, Petrovic M, Jankovic Z, Jaukovic Lj, Sobic-Saranovic D, Grozdic I, Odalovic S, Pavlovic S, Jaksic E, Zuvela M, Ajdinovic B, Matic S, Obradovic V. Scintigraphic detection of colon carcinomas with iodinated monoclonal antibodies. J BUON 2012;17:695-9.
5. Janković M.M, Pijetlović B, Koljević-Marković A, Todorović-Tirnanić M, Beatović S, Antić V, Odalović S, Sekulić S, Jorgovanović N, Popović DB. GammaKey system for improved diagnostics with gamma cameras. Comput Biol Med 2014; 50: 97-106.
6. Artiko V, Odalovic S, Sobic-Saranovic D, Petrovic M, Stojiljkovic M, Petrovic N, Kozarevic N, Grozdic-Milojevic I, Obradovic V. Can (18)F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study. Hell J Nucl Med 2015; 18:35-41.
7. Odalovic S, Artiko V, Sobic-Saranovic D, Stojiljkovic M, Petrovic M, Petrovic N, Kozarevic N, Grozdic-Milojevic I, Obradovic V. The diagnostic performance and added value of (18)F-FDG PET/CT in the detection of liver metastases in recurrent colorectal carcinoma patients. Hell J Nucl Med 2015;18:81-7.
8. Sobic-Saranovic D, Petrusic I, Artiko V, Pavlovic S, Subotic S, Saranovic D, Nagorni-Obradovic L, Petrovic N, Todorovic-Tirnanic M, Odalovic S, Grozdic-Milojevic I, Stojiljkovic M, Obradovic V. Comparison of 18F-FDG PET/CT and MDCT for staging/restaging of non-small cell lung cancer. Neoplasma 2015; 62:295-301.
9. Grozdic Milojevic I, Sobic-Saranovic D, Videnovic-Ivanov J, Saranovic D, Odalovic S, Artiko V. FDG PET/CT in bone sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2016; 33:66-74.
10. Sobic Saranovic D, Stojiljkovic M, Susnjar S, Odalovic S, Artiko V, Pavlovic S, Grozdic-Milojevic I, Obradovic V. Metabolic activity of breast cancer metastatic lesions on positron emission tomography/computed tomography: comparison with histological and biological characteristics of primary tumor. Neoplasma 2016; 63:313-21.
11. Brajkovic L, Kostic V,  Sobic-Saranovic D,  Stefanova E, D  Jecmenica-Lukic M,  Jesic A,  Stojiljkovic M,  Odalovic S,   Gallivanone F,  Castiglioni I,  Radovic B,  Trajkovic G,  Artiko V. The utility of FDG-PET in the differential diagnosis of Parkinsonism. Neurological research 2017; 39: 675-84.
12. Odalovic S, Stojiljkovic M, Sobic-Saranovic D, Pandurevic S, Brajkovic L, Milosevic I, Grozdic-Milojevic I, Artiko V. Prospective study on diagnostic and prognostic significance of postoperative FDG PET/CT in recurrent colorectal carcinoma patients: comparison with MRI and tumor markers. Neoplasma 2017; 64:954-61.
13. Saponjski J, Sobic-Saranovic D, Petrovic N, Odalovic S, Artiko V, Stojiljkovic M, Rankovic N, Veljkovic M, Vukicevic M, Bogosavljevic N, Jeremic D, Saponjski D. Hybrid imaging of vascular graft infection by positron emission tomography with computed tomography using fluorine-18-labeled fluorodeoxyglucose: the Serbian National PET Center experience. Srp Arh Celok Lek, 2019; 147: 405-9.
14. Odalović S, Sobić-Saranović D, Pavlović S, Grozdić I, Saranović Đ, Petrović M, Milovanović A, Petrašinović Z, Đurić-Stefanović A, Obradović V. Preliminary experience with 18f-fluoro-deoxy-glucose positron emission tomography/computed tomography in pediatric oncology patients. Acta Chir Iugosl 2011; 58:67-73
15. Janković MM, Koljević-Marković A, Odalović S, Popović DB, Petrović N, Artiko V. A software tool for the assessment of salivary gland function. Telfor Journal 2014; 6: 59-63.